Spyre Therapeutics Inc.

12.43
0.01 (0.08%)
At close: Apr 17, 2025, 10:52 AM

Spyre Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
89.42M 188.89M 34.86M 15.14M 90.09M 19.25M 22.46M 12.82M 47.75M
513.66M 150.38M 20.85M 77.99M 56.18M 52.7M 52.05M 37.48M 15.75M
n/a n/a 1.55M 1.84M 1.84M 1.5M n/a n/a n/a
10K 331K 683K 842K 115K 11K 50K 232K 40K
n/a n/a 375K 815K n/a n/a n/a 3.08M 1.22M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
5.39M 2.25M 6.17M n/a n/a n/a n/a n/a n/a
608.47M 341.53M 62.26M 98.89M 149.79M 74.5M 76.67M 54.99M 66.42M
n/a n/a 6.65M 8.36M 9.87M 7.17M 1.02M 854K 599K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
10K 331K 8.89M 11.04M 11.83M 8.68M 1.07M 1.09M 639K
608.48M 341.86M 71.14M 109.93M 161.62M 83.18M 77.74M 56.08M 67.06M
666K 896K 677K 3.32M 2.25M 3.15M 663K 389K 168K
n/a n/a 517K 2.36M 13.41M n/a n/a 20K 71K
n/a n/a n/a n/a n/a n/a n/a n/a n/a
53.39M 27.03M 4.92M 4.99M 4.18M 3.74M 6.93M 3.38M 2.46M
54.06M 31.98M 14.66M 20.14M 16.44M 18.36M 10.24M 5.63M 3.96M
n/a n/a n/a n/a n/a n/a n/a n/a n/a
36.62M 125.86M n/a n/a 214K 31K 72K 111K 132K
36.62M 125.86M 6.18M 5.84M 5.34M 4.74M 72K 111K 132K
90.68M 157.84M 20.84M 25.98M 21.79M 23.1M 10.31M 5.74M 4.1M
n/a 84.56M 4.63M 5.06M 5.45M 5.12M n/a n/a n/a
13K 10K 6K 5K 5K 3K 2K 2K 1K
-972.43M -764.41M -425.62M -341.81M -276.01M -195.12M -116.86M -72.51M -45.28M
180K 302K -48K -20K 11K 51K -27K -102K -4K
517.8M 184.02M 50.3M 83.94M 139.83M 60.08M 67.43M 50.34M 62.97M
513.66M 150.38M 20.85M 77.99M 56.18M 54.2M 52.05M 37.48M 15.75M